Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.520
+0.180 (5.39%)
At close: Jun 26, 2026, 4:00 PM EDT
3.519
-0.001 (-0.02%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Recursion Pharmaceuticals Employees
Recursion Pharmaceuticals had 600 employees as of December 31, 2025. The number of employees decreased by 200 or -25.00% compared to the previous year.
Employees
600
Change (1Y)
-200
Growth (1Y)
-25.00%
Revenue / Employee
$110,680
Profits / Employee
-$932,960
Market Cap
1.87B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| AbCellera Biologics | 562 |
| Vir Biotechnology | 367 |
| UroGen Pharma | 298 |
| Syndax Pharmaceuticals | 298 |
| Capricor Therapeutics | 231 |
| Septerna | 130 |
| AnaptysBio | 104 |
| Bicara Therapeutics | 103 |
RXRX News
- 2 days ago - Cathie Wood’s ARK Investment buys 260K shares of Recursion Pharmaceuticals today - TheFly
- 9 days ago - Recursion Pharmaceuticals Transcript: AGM 2026 - Transcripts
- 17 days ago - Recursion Pharmaceuticals Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 24 days ago - Recursion to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules - GlobeNewsWire
- 5 weeks ago - Altitude Lab Portfolio Companies Surpass $205 Million in Funding, Marking a New Era for Early-Stage Biotechs in Salt Lake City - GlobeNewsWire
- 6 weeks ago - Recursion Pharmaceuticals price target raised to $5.50 from $5 at Morgan Stanley - TheFly
- 6 weeks ago - Recursion Pharmaceuticals Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts